Publication | Closed Access

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaPrognosisHematologyMyeloid NeoplasiaMalignant Blood DisorderMedicineRadiation OncologyHealth Sciences